These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1391006)

  • 1. [In vitro activity of 11 antimicrobial agents against clinical isolates of Acinetobacter spp].
    Gómez-Garcés JL; Alós JI; Pérez-Rivilla A; Cogollos R; Amor E
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):313-4. PubMed ID: 1391006
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
    Park YK; Choi JY; Song JH; Ko KS
    Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
    López-Hernández S; Alarcón T; López-Brea M
    Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
    Unal S; Garcia-Rodriguez JA
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of acinetobacter anitratus in urinary isolates at G.M. & Associated Hospitals, KC's Medical College, Lucknow, UP.
    Banerjee G; Agarwal SK
    Indian J Pathol Microbiol; 2001 Jan; 44(1):81. PubMed ID: 12562009
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of Acinetobacter strains isolated from a hospital environment. II. Drug resistance of Acinetobacter strains isolated from a hospital environment].
    Bugalski R; Gospodarek E; Gołuszko P
    Med Dosw Mikrobiol; 1987; 39(2):118-23. PubMed ID: 3657328
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
    Tognim MC; Andrade SS; Silbert S; Gales AC; Jones RN; Sader HS
    Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of multidrug-resistant isolates of Acinetobacter baumannii.
    Okpara AU; Maswoswe JJ
    Am J Hosp Pharm; 1994 Nov; 51(21):2671-5. PubMed ID: 7856578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility and REP-PCR fingerprints of Acinetobacter spp. isolated from a hospital ten years apart.
    Misbah S; AbuBakar S; Hassan H; Hanifah YA; Yusof MY
    J Hosp Infect; 2004 Dec; 58(4):254-61. PubMed ID: 15564001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile].
    Silva J; Avello C; Matamoro F; Villagra L; Rojas V; Sandoval L
    Rev Med Chil; 1999 Aug; 127(8):926-34. PubMed ID: 10752253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Bérézin E
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):625-8. PubMed ID: 3534756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
    Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
    Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiological and therapeutic considerations of Acinetobacter spp. infection].
    López-Brea M; Alarcón T; López S
    Rev Esp Quimioter; 1998 Jun; 11(2):110-7. PubMed ID: 9795295
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiological characterization of hospital-acquired Acinetobacter baumannii isolates from a 1500-bed teaching hospital by phenotypic and genotypic methods.
    Basustaoglu AC; Kisa O; Sacilik SC; Ozyurt M; Yildiran ST
    J Hosp Infect; 2001 Mar; 47(3):246-7. PubMed ID: 11247688
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].
    Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E
    Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is sulbactam really the answer for treatment of infections caused by multiresistant strains of Acinetobacter spp.?].
    Casellas JM; Dana R
    Enferm Infecc Microbiol Clin; 1997; 15(6):335-6. PubMed ID: 9376409
    [No Abstract]   [Full Text] [Related]  

  • 19. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
    Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
    J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamase producing Acinetobacter species in hospitalized patients.
    Kansal R; Pandey A; Asthana AK
    Indian J Pathol Microbiol; 2009; 52(3):456-7. PubMed ID: 19680002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.